SC 13G - AJ KAZIMI 2017

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

February 9, 2018

Accession Number

0001628280-18-001351

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →